• 1
    Barlliot I, Horriot JC, Pigneux J et al. Carcinoma of the intact uterine cervix treated with radiotherapy alone: a French cooperative study: update and multivariate analysis of prognostic factors. Int J Radiat Oncol Biol Phys 1997; 38: 96978.
  • 2
    Yalman D, Aras AB, Ozkök S et al. Prognostic factors in definitive radiotherapy of uterine cervical cancer. Eur J Gynaecol Oncol 2003; 24: 30914.
  • 3
    Munzenrider JE. Recent advances in radiotherapy. Rev Interam Radiol 1977; 2: 12333.
  • 4
    Milsom I, Friberg LG. Primary adenocarcinoma of the uterine cervix. A clinical study. Cancer 1983; 52: 9427.
  • 5
    Guichard M, Weichselbaum RR, Little JB, Malaise EP. Potentially lethal damage repair as a possible determinant of human tumour radiosensitivity. Radiother Oncol 1984; 1: 2639.
  • 6
    Shibamoto Y, Yukawa Y, Tsutsui K, Takahashi M, Abe M. Variation in the hypoxic fraction among mouse tumors of different types, sizes, and sites. Jpn J Cancer Res 1986; 77: 90815.
  • 7
    Stanley JA, Shipley WU, Steel GG. Influence of tumour size on hypoxic fraction and therapeutic sensitivity of Lewis lung tumour. Br J Cancer 1977; 36: 10513.
  • 8
    Overgaard J, Hansen HS, Andersen AP et al. Misonidazole combined with split-course radiotherapy in the treatment of invasive carcinoma of larynx and pharynx: report from the DAHANCA 2 study. Int J Radiat Oncol Biol Phys 1989; 16: 10658.
  • 9
    Grogan M, Thomas GM, Melamed I et al. The importance of hemoglobin levels during radiotherapy for carcinoma of the cervix. Cancer 1999; 86: 152836.
  • 10
    Henke M, Sindlinger F, Ikenberg H, Gerds T, Schumacher M. Blood hemoglobin level and treatment outcome of early breast cancer. Strahlenther Onkol 2004; 180: 4551.
  • 11
    Hoff CM, Hansen HS, Overgaard M et al. The importance of haemoglobin level and effect of transfusion in HNSCC patients treated with radiotherapy – Results from the randomized DAHANCA 5 study. Radiother Oncol 2011; 98: 2333.
  • 12
    Mortensen LS, Busk M, Nordmark M et al. Accessing radiation response using hypoxia PET imaging and oxygen sensitive electrodes: a preclinical study. Radiother Oncol 2011; 99: 41823.
  • 13
    Shibamoto Y, Sugie C, Iwata H. Radiotherapy for metastatic brain tumors. Int J Clin Oncol 2009; 14: 2818.
  • 14
    Rahn DA III, Ray DK, Schlesinger DJ et al. Gamma knife radiosurgery for brain metastasis of nonsmall cell lung cancer: is there a difference in outcome between morning and afternoon treatment? Cancer 2011; 117: 41420.
  • 15
    Mori Y, Kobayashi T, Shibamoto Y. Stereotactic radiosurgery for metastatic tumors in the pituitary gland and the cavernous sinus. J Neurosurg 2006; 105(Suppl): 3742.
  • 16
    Serizawa T, Hirai T, Nagano O et al. Gamma knife surgery for 1–10 brain metastases without prophylactic whole-brain radiation therapy: analysis of cases meeting the Japanese prospective multi-institute study (JLGK0901) inclusion criteria. J Neurooncol 2010; 98: 1637.
  • 17
    Motulsky H. Appropriate sample size. In: Motulsky H ed.; Tsuzaki K, trans. Intuitive Biostatics. Tokyo: Science Medical, 1997; 196205.
  • 18
    Nagai A, Shibamoto Y, Mori Y et al. Increases in the number of brain metastases detected at frame-fixed, thin-slice MRI for gamma knife surgery planning. Neuro Oncol 2010; 12: 118792.
  • 19
    Kim SK, Kondziolka D, Flickinger JC et al. Stereotactic radiosurgery for patients with non-small cell lung carcinoma metastatic to brain. Cancer 1997; 80: 207583.
  • 20
    Serizawa T, Ono J, Iichi T et al. Gamma knife radiosurgery for metastatic brain tumors from lung cancer: a comparison between small cell and non-small cell carcinoma. J Neurosurg 2002; 97 (Suppl 5): 4848.
  • 21
    Ohta Y, Oda M, Tsunezuka Y et al. Results of recent therapy for non-small cell lung cancer with brain metastasis as the initial relapse. Am J Clin Oncol 2002; 25: 4769.
  • 22
    Pan HC, Sheehan J, Stroila M, Steiner M, Steiner L. Gamma knife surgery for brain metastases from lung cancer. J Neurosurg (Suppl) 2005; 102: 12833.
  • 23
    Nakagawa K, Tago M, Terahara A et al. A single institutional outcome analysis of Gamma Knife radiosurgery for single or multiple brain metastases. Clin Neurol Neurosurg 2000; 102: 22732.
  • 24
    Ohmori T, Podack ER, Nishio K et al. Apoptosis of lung cancer cells caused by some anti-cancer agents (MMC, CPT-11, ADM) is inhibited by bcl-2. Biochem Biophy Res Commun 1993; 192: 306.
  • 25
    Watanabe H, Kanamori I, Ohno K et al. Tumor biology. In: Watanabe H, Kanamori I, eds. Introduction to Radiotherapy, 2nd edn (in Japanese). Tokyo: Iryo Kagaku Sha; 2008: 130.
  • 26
    Tsukahara Y, Sakai Y, Noguchi H, Iwai S, Fukuta T. A study on radiosensitivity and prognostic factors of cervical adenocarcinoma. Acta Obst Gynaec Jpn 1980; 32: 160914.
  • 27
    Perez CA, Stanley K, Rubin P et al. A prospective randomized study of various irradiation doses and fractionation schedules in the treatment of inoperable non-oat-cell carcinoma of the lung. Cancer 1980; 45: 274453.
  • 28
    Shibamoto Y, Hashizume C, Baba F et al. Stereotactic body radiotherapy using a radiobiology-based regimen for stage I nonsmall cell lung cancer: a multicenter study. Cancer 2012; 118: 207884.
  • 29
    Shibamoto Y, Shibata T, Miyatake S et al. Assessment of the proliferative activity and radiosensitivity of human tumours using the cytokinesis-block micronucleus assay. Br J Cancer 1994; 70: 6771.
  • 30
    West CM, Davidson SE, Burt PA, Hunter RD. The intrinsic radiosensitivity of cervical carcinoma: correlations with clinical data. Int J Radiat Oncol Biol Phys 1995; 31: 8416.
  • 31
    Shibamoto Y, Ike O, Mizuno H et al. Proliferative activity and micronucleus frequency after radiation of lung cancer cells as assessed by the cytokinesis-block method and their relationship to clinical outcome. Clin Cancer Res 1998; 4: 67782.
  • 32
    Hasegawa T, Kondziolka D, Flickinger JC et al. Stereotactic radiosurgery for brain metastases from gastrointestinal tract cancer. Surg Neurol 2003; 60: 50615.
  • 33
    Takeda A, Kunieda E, Ohashi T et al. Stereotactic body radiotherapy (SBRT) for oligometastatic lung tumors from colorectal cancer and other primary cancers in comparison with primary lung cancer. Radiother Oncol 2011; 101: 2559.
  • 34
    Iwata H, Murai T, Shibamoto Y. Radiation response of the normal lung tissue and lung tumors. In: Jeremic B ed. Advances in Radiation Oncology in Lung Cancer, 2nd edn. Berlin, Heidelberg: Springer-Verlag, 2011: 11928.
  • 35
    Varlotte J, Stevenson MA. Anemia, tumor hypoxemia, and the cancer patient. Int J Radiat Oncol Biol Phys 2005; 63: 2536.